INSMED Inc
INSM· Nasdaq
INSMINSMED Inc
Filed Aug 6, 2026 · 10-Q · 37 days after period end · 0001104506-26-000041
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $425.49M | $107.42M | $90.34M | $77.23M |
| Net Income | -$13.24M | -$321.69M | -$300.61M | -$244.81M |
| EPS Diluted | -$0.06 | -$1.70 | -$1.94 | -$1.78 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 6, 2026 · 37 d after period end
